Parejo NA - Search Results

1

The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis.

Opal SM, Palardy JE, Parejo NA, Creasey AA. Opal SM, et al. Among authors: parejo na. Crit Care Med. 2001 Jan;29(1):13-7. doi: 10.1097/00003246-200101000-00003. Crit Care Med. 2001. PMID: 11176151

2

Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection.

Lutterloh EC, Opal SM, Pittman DD, Keith JC Jr, Tan XY, Clancy BM, Palmer H, Milarski K, Sun Y, Palardy JE, Parejo NA, Kessimian N. Lutterloh EC, et al. Among authors: parejo na. Crit Care. 2007;11(6):R122. doi: 10.1186/cc6184. Crit Care. 2007. PMID: 18042296 Free PMC article.

3

Potential hazards of combination immunotherapy in the treatment of experimental septic shock.

Opal SM, Cross AS, Jhung JW, Young LD, Palardy JE, Parejo NA, Donsky C. Opal SM, et al. Among authors: parejo na. J Infect Dis. 1996 Jun;173(6):1415-21. doi: 10.1093/infdis/173.6.1415. J Infect Dis. 1996. PMID: 8648214

4

Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock.

Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH. Opal SM, et al. Among authors: parejo na. J Infect Dis. 1999 Nov;180(5):1584-9. doi: 10.1086/315093. J Infect Dis. 1999. PMID: 10515819

5

Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection.

Opal SM, Sypek JP, Keith JC Jr, Schaub RG, Palardy JE, Parejo NA. Opal SM, et al. Among authors: parejo na. Shock. 2001 Apr;15(4):285-90. doi: 10.1097/00024382-200115040-00006. Shock. 2001. PMID: 11303727

6

The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsis.

Chahin A, Opal SM, Zorzopulos J, Jobes DV, Migdady Y, Yamamoto M, Parejo N, Palardy JE, Horn DL. Chahin A, et al. Antimicrob Agents Chemother. 2015 Feb;59(2):1225-9. doi: 10.1128/AAC.03923-14. Epub 2014 Dec 15. Antimicrob Agents Chemother. 2015. PMID: 25512413 Free PMC article.

7

PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS.

Opal SM, Ellis JL, Suri V, Freudenberg JM, Vlasuk GP, Li Y, Chahin AB, Palardy JE, Parejo N, Yamamoto M, Chahin A, Kessimian N. Opal SM, et al. Shock. 2016 Apr;45(4):411-8. doi: 10.1097/SHK.0000000000000528. Shock. 2016. PMID: 26974318

8

Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication.

Opal SM, Artenstein AW, Cristofaro PA, Jhung JW, Palardy JE, Parejo NA, Lim YP. Opal SM, et al. Among authors: parejo na. Infect Immun. 2005 Aug;73(8):5101-5. doi: 10.1128/IAI.73.8.5101-5105.2005. Infect Immun. 2005. PMID: 16041026 Free PMC article.

9

Recombinant human interleukin-11 in experimental Pseudomonas aeruginosa sepsis in immunocompromised animals.

Opal SM, Jhung JW, Keith JC Jr, Palardy JE, Parejo NA, Young LD, Bhattacharjee A. Opal SM, et al. Among authors: parejo na. J Infect Dis. 1998 Oct;178(4):1205-8. doi: 10.1086/515686. J Infect Dis. 1998. PMID: 9806062

10

Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis.

Opal SM, Jhung JW, Keith JC Jr, Goldman SJ, Palardy JE, Parejo NA. Opal SM, et al. Among authors: parejo na. Blood. 1999 May 15;93(10):3467-72. Blood. 1999. PMID: 10233899 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters